Abstract
Relapse represents a consistent clinical problem for individuals with substance use disorder. In the incubation of craving model of persistent craving and relapse, cue-induced drug seeking progressively intensifies or “incubates” during the first weeks of abstinence from drug self-administration and then remains high for months. Previously, we and others have demonstrated that expression of incubated cocaine craving requires strengthening of excitatory synaptic transmission in the nucleus accumbens core (NAcc). However, despite the importance of dopaminergic signaling in the NAcc for motivated behavior, little is known about the role that dopamine (DA) plays in the incubation of cocaine craving. Here we used fiber photometry to measure DA transients in the NAcc of male and female rats during cue-induced seeking tests conducted in early abstinence from cocaine self-administration, prior to incubation, and late abstinence, after incubation of craving has plateaued. We observed DA transients time-locked to cue-induced responding but their magnitude did not differ significantly when measured during early versus late abstinence seeking tests. Next, we tested for a functional role of these DA transients by injecting DA receptor antagonists into the NAcc just before the cue-induced seeking test. Blockade of either D1 or D2 DA receptors reduced cue-induced cocaine seeking after but not before incubation. We found no main effect of sex or significant interaction of sex with other factors in our experiments. These results suggest that DA contributes to incubated cocaine seeking but the emergence of this role reflects changes in postsynaptic responsiveness to DA rather than presynaptic alterations.
Similar content being viewed by others
Introduction
A major difficulty in treating substance use disorder is the propensity for relapse in abstinent individuals. “Incubation of craving” is a leading preclinical model for studying vulnerability to cue-induced relapse after protracted abstinence from drug self-administration. It is based on the discovery that cue-induced cocaine seeking in rats progressively increased (“incubated”) over the first weeks of abstinence and then remained high for additional months before declining, providing a model for persistent vulnerability to relapse [1,2,3]. Incubation has subsequently been demonstrated for other addictive drugs [4,5,6] and in humans [7,8,9,10].
Although many brain regions contribute to incubation of cocaine craving [6, 11], our lab and others have shown that synaptic plasticity leading to strengthening of excitatory synapses on medium spiny neurons (MSN) in the NAc core (NAcc) and shell (NAcs) subregions is necessary for its expression [11, 12]. In contrast, very little is known about the role of NAc dopamine (DA) in incubation of cocaine craving. This is a significant knowledge gap since DA transmission in the NAc is essential for stimulus-reward learning and motivated behavior [13,14,15,16]. Most relevant to the incubation model, microdialysis and voltammetry studies have shown that DA release is associated with presentations of reward-related cues and the ability of such cues to promote reward seeking, both for natural rewards [e.g., [17,18,19]] and cocaine [e.g., [20,21,22]]. More recently, fiber photometry studies have detected DA transients in NAcc during cue-induced reinstatement of cocaine seeking [23] and in lateral shell in association with context-induced cocaine seeking [24].
Surprisingly, no studies have measured DA release during expression of cocaine incubation. Here we used fiber photometry paired with the DA biosensor GRAB_DA2m [25, 26] to assess DA release in the NAcc during cue-induced seeking tests following long-access cocaine self-administration on forced abstinence day (FAD) 1–2, prior to incubation, and FAD40-50, after incubation. Then we tested the functional significance of this DA release by infusing DA D1-class and D2-class receptor (D1R and D2R) antagonists into the NAcc prior to seeking tests.
Materials and methods
Details are in Supplementary Methods.
Subjects and surgery
Procedures followed the NIH Guide for the Care and Use of Laboratory Animals and were approved by the OHSU IACUC. Male and female Long-Evans rats were used (Table S1). Rats for fiber photometry received jugular catheters, bilateral infusions of AAV9-hSyn-GRAB_DA2m or AAV9-hSyn-GRAB_DAmut into NAcc, and fiber optic cannula implantation above each infusion site. Rats for pharmacology experiments were implanted with jugular catheters and bilateral 23-gauge guide cannula above the NAcc. After recovery, rats underwent cocaine self-administration training (0.5 mg/kg/infusion; 6 h/day × 10 days).
Fiber photometry recordings
During cue-induced seeking tests on FAD1-2 or FAD40-50, we used the TDT RZ10x system to record DA and isosbestic channels.
Intra-NAcc microinjections
Rats received the D1R antagonist SCH39166, the D2R antagonist L-741,626, or vehicle prior to cue-induced seeking or open field tests.
Analysis
Fiber photometry data were analyzed using GuPPy [27]. Full statistical analysis of processed photometry data and behavioral data are shown in Supplemental Tables 2–10.
Results
Expression of GRAB_DA2m does not alter cocaine self-administration or incubation of craving
As our experiments are long in duration (see Timeline in Fig. 1A), we began by determining the stability of virus expression. Drug-naïve rats received NAcc infusion of an AAV expressing GRAB_DA2m and were killed after 3–10 weeks to parallel timing of cue-induced seeking tests in subsequent experiments. Immunohistochemical analysis demonstrated stable expression over this period (Fig. 1B; t11 = 0.110, p = 0.915; Table S2 contains this and all other statistical analyses for Fig. 1).
Next, we tested whether expression of the sensor, which potentially could lead to buffering of DA levels, might be affecting our measured behaviors. Rats underwent intra-NAcc infusion of GRAB_DA2m or a mutant version that does not bind DA (GRAB_DAmut), implantation of a fiber optic cannula above the area of virus expression, and implantation of a jugular catheter, followed by cocaine self-administration training (Fig. 1A, C). During training, nose-pokes in the active port triggered cocaine infusion and a 4-s light cue/simultaneous 4-s time-out period. Both virus groups acquired cocaine self-administration and earned a similar number of infusions (Fig. 1D). Analysis revealed significant effects of session and port, but not virus. For one rat, inactive port data on days 6–7 were excluded as outliers; see Fig. S1 for full data. After 10 days of self-administration, rats received cue-induced seeking tests on FAD1-2 and FAD40-50 (within-subject design), during which pokes in the active port triggered the cue but no cocaine infusion (Fig. 1D-right). Mixed effects analysis revealed no effect of virus on drug seeking but a main effect of test day (F1,21 = 7.526, p = 0.0122) and port (F1,21 = 50.1, p < 0.001) with an interaction between port and test day (F1,21 = 9.071, p = 0.00664), indicative of incubation. We found no main effect of sex for any measure related to cocaine self-administration or cue-induced seeking (Fig. S2A and Table S3).
Responding for cocaine cues elicits similar DA responses in early and late abstinence
Fiber photometry recordings were performed in both GRAB_DA2m and GRAB_DAmut rats during FAD1-2 and FAD40-50 seeking tests (Fig. 2A). As expected, there was no apparent signal for GRAB_DAmut-expressing rats (Fig. S3), so we used their data to define analysis thresholds (see below).
Photometry data for GRAB_DA2m-expressing rats on FAD1-2 and FAD40-50 are presented in Fig. 2B. Full statistical analysis for these and other data in Fig. 2 are presented in Tables S4 and S6. DA levels, plotted relative to each nose-poke (time 0), are shown for pokes in the active port that triggered the cue light (Fig. 2B-left), pokes in the active hole that did not trigger cue presentation because they occurred during the 4-s time-out period when the cue light is already on (Fig. 2B-center), and pokes in the inactive port (Fig. 2B-right). Horizontal lines above the traces indicate DA response duration assessed using continuous threshold bootstrapping methods, where the 95% confidence interval does not cross baseline (z-score = 0) for the consecutive threshold period [28,29,30], with the consecutive threshold defined using GRAB_DAmut data (see Supplementary Methods). Periods during which bootstrapping revealed between-group differences are indicated by a dark blue line.
Focusing on active pokes triggering the cue, analysis of both FAD1-2 and FAD40-50 revealed an increase in DA levels at cue onset (0–1 s) as well as a smaller amplitude but longer-lasting increase during the remainder of cue light presentation (1–4 s) (Fig. 2B-left). Although there were small differences in the exact timing of DA increases (see colored bars above traces), we found no significant differences between test days when comparing bootstrapped confidence intervals. We also quantified both periods relative to baseline (−2 to 0 s) via area under the curve (AUC) (Fig. 2C-left). This revealed a significant effect of time (F2,32 = 14.0, p < 0.0001) but not test day (FAD1-2 vs FAD40-50) and no significant interaction. We found similar results when examining the maximum amplitude (Fig. S4 and Table S4). These data indicate that, compared to baseline, active pokes triggering the cue elicit DA release that is of similar magnitude on FAD1-2 and FAD40-50 when averaged across trials and subjects. However, heat maps showing the average DA response for each subject revealed considerable variability (Fig. 2D). This variability could have many origins, including individual differences in drug responding [e.g., [31]] and the area of NAcc targeted [32]. We examined the potential relationship between our DA signals and several behavioral measures as well as fiber optic placement along the rostral/caudal axis (Fig. S5) but did not observe any significant correlations, possibly due to low sample size.
Next, we performed the same analyses for active port nose-pokes made within the time-out period (Cue light on) (Fig. 2B-middle, Tables S4 and S6). The pattern of DA responses was similar to that in Fig. 2B-left, but less robust, with only the initial response detected by bootstrapping. Again, no difference between test days was indicated. Mixed effects analysis of AUC for 0–1 s and 1–4 s time periods (relative to −2 to 0 s baseline) found no significant effect of time or test day (Fig. 2C-middle).
We also examined the DA response to inactive pokes (Fig. 2B-right, Tables S4 and S6). Here, bootstrapping identified a very brief increase shortly after the nose-poke on FAD40-50, and a more delayed response (~2 s) that differed significantly between test days. Analysis of AUC revealed a significant effect of time (F2,32 = 6.97, p = 0.00307) but not test day and no significant interaction (Fig. 2C-right). Overall, Fig. 2B suggests that the DA response immediately associated with the nose-poke (0–1 s) is greater for active than inactive pokes.
We analyzed frequency and amplitude of all DA transients over the 30-min test, regardless of whether they were time-locked to a nose-poke (Fig. 2E and Table S4). We used GRAB_DA2mut data to define a threshold for DA transient identification such that zero peaks were detected in the mutant trace after applying this threshold (Supplementary Methods). The frequency of DA transients did not differ between test days, but the average amplitude of all above-noise DA events was significantly reduced on FAD40-50 versus FAD1-2 (t16 = 2.84, p = 0.0117). More work is necessary to determine the mechanism of this effect (presynaptic vs postsynaptic) and whether it contributes to the time-dependent cascade that underlies the incubation phenomenon. However, with respect to expression of incubation, the focus of our study, our data on DA events time-locked to nose-pokes are most relevant and these data argue against a presynaptic mechanism.
We investigated within-session effects by binning seeking test data into three 10-min bins. Behaviorally, we observed greater active port responses across bins on FAD40-50 vs FAD1-2, reflecting incubation of craving (Fig. 3B and Table S2; main effect of test day: F1,17 = 10.7, p = 0.0001). For photometry data, visual inspection suggested variability across bins on FAD1-2, with the highest magnitude DA response in the first 10 min, whereas responses in each bin appeared similar on FAD40-50 (Fig. 3C). A concern when comparing the two test days is that we averaged different numbers of DA responses. Thus, because of the incubation phenomenon, rats made more active port responses on FAD40-50 than FAD1-2. This would be expected to reduce variability for the FAD40-50 test. To control for this, we analyzed the DA response to the first nose-poke in each 10-min bin, so that each rat has only one poke/DA response contributing to each bin for each test day. When analyzed in this manner, the pattern of responding across bins appeared similar on FAD1-2 and FAD40-50 (Fig. 3D). We also compared the DA response to the first nose-poke of each session and observed no difference between test days (Fig. 3E and Table S5). Thus, within-session DA responses do not differ between test days when accounting for the number of responses in the data sets.
Males and females exhibited a similar pattern of DA release during seeking tests (no main effect of sex: F1,30 = 1.10, p = 0.304), although small time-dependent differences between the sexes were suggested by disaggregated data (Fig. S2B and Table S5). We cannot draw conclusions about potential influence of the estrous cycle. While there is evidence that DA transmission is modulated by the estrous cycle [33, 34] and that females in estrus show potentiated cocaine seeking [35,36,37], very few of our females were in estrus at the time of testing (Fig. S2C).
Intra-NAcc administration of a D1R antagonist decreases expression of cocaine incubation
To determine whether DA responses during cue-induced seeking tests have behavioral significance, we infused D1R or D2R antagonists into NAcc 15 min prior to cue-induced seeking tests on FAD1 or FAD40-50. Results obtained with the D1R antagonist SCH39166 are shown in Fig. 4 (full statistics in Table S7). After self-administration training, rats were divided into equivalent groups, destined for vehicle or SCH39166 infusion, based on cocaine infusions on the last three self-administration days (sessions 8–10) (Fig. 4B-left). For rats assigned to the FAD40-50 test group, vehicle and SCH39166 groups were also balanced based on results of the FAD1 seeking test (Fig. S6A).
Infusion of SCH39166 (1 µg/0.5 µL) in NAcc (placements shown in Fig. S7) did not affect cue-induced seeking on FAD1 compared to vehicle-infused rats (Fig. 4B-right). When we binned the 1-h test into three 20-min bins, a mixed effects analysis showed a significant effect of bin (F2,36 = 4.36, p = 0.0202) but not treatment and no significant treatment x bin interaction. In contrast, when the D1R antagonist was infused prior to a FAD40-50 test, it significantly suppressed incubated cue-induced seeking (Fig. 4D-middle; treatment × port: F1,26 = 6.03, p = 0.0210) specifically on the active port (t52 = 4.44, p < 0.0001). Analysis of binned data from FAD40-50 (Fig. 4D-right) revealed a significant effect of treatment (F1,26 = 16.7, p = 0.0124) and bin (F2,52 = 4.79, p = 0.000377), but no interaction. We found no main effect of sex when analyzing aggregated data from this experiment (Table S8), although disaggregated data may suggest a more robust effect in males (Fig. S6B). Overall, these data indicate that D1R blockade significantly reduced seeking on FAD40-50 but not FAD1.
Because DA receptor antagonists could reduce drug seeking via a general reduction in motor behavior, we monitored locomotor activity during seeking tests using photobeams in operant chambers. SCH39166 significantly reduced beam-breaks on FAD1 (Fig. 4E-left; t17 = 4.32, p = 0.000500) but not FAD40-50 (Fig. 4E-middle). We also tested the effect of intra-NAcc vehicle or SCH39166 (same dose) on open field behavior in drug-naïve rats and found no effect of treatment (Fig. 4E-right). These results, combined with no significant effect of SCH39166 on inactive nose-pokes (Fig. 4D-middle), suggest that the observed effect of D1R antagonism on FAD40-50 cue-induced seeking does not reflect a general reduction in motor behavior.
Intra-NAc administration of a D2 antagonist decreases expression of cocaine incubation
We performed a parallel experiment using the highly specific D2R antagonist L-741,626 and its vehicle (Fig. 5; full statistics in Table S9). Intra-NAcc infusion of L-741,626 (1 µg/0.5 µL; placements shown in Fig. S9) did not affect cue-induced seeking when given prior to the FAD1 test (Fig. 5B-middle). There was also no effect of treatment when we split the 1-h FAD1 seeking test into 20-min bins (Fig. 5B-right). However, similar to D1R antagonism, we observed a significant suppression of incubated cue-induced seeking when L-741,626 was given on FAD40-50 (Fig. 5D-right; treatment x port interaction: F1,21 = 7.06, p = 0.0148). Post hoc analysis confirmed that L-741,626 specifically reduced active port responding (t42 = 3.46, p = 0.00251). We performed the same analysis after binning the data and found a main effect of treatment (F1,21 = 6.32, p = 0.0202) and bin (F2,42 = 5.41, p = 0.00811), but no interaction. Analysis of aggregated data from this experiment found no main effect of sex (Table S10), but disaggregated data may suggest a more robust effect of L-741,626 in males (Fig. S8B and Table S10). Overall, these data indicate that D2R blockade significantly reduced incubated cue-induced seeking on FAD40-50 but not FAD1 seeking.
To test for effects of the D2R antagonist on locomotion, we analyzed beam breaks in the operant chamber during seeking tests and found no significant difference between the L-741,626 and vehicle groups on FAD1 or FAD40-50 (Fig. 5E-left and middle). We also tested a separate cohort of drug-naïve rats for open field locomotion and found no effect of treatment (Fig. 5E-right). These data, along with no effect of L-741,626 on inactive nose-pokes (Fig. 5D-middle), indicate that the effect of D2R antagonism on incubated cue-induced seeking is not due to motor impairment.
Discussion
During cue-induced seeking tests conducted during forced abstinence from cocaine self-administration, we used fiber photometry to detect DA transients time-locked to nose-pokes that triggered presentation of the cue previously paired with cocaine infusions. We found that the magnitude of this DA response did not differ significantly on FAD1-2 and FAD40-50. To test the functional significance of this DA release, we performed intra-NAcc injections of the D1R antagonist SCH39166 prior to FAD1 or FAD40-50 seeking tests. When given on FAD1, we found no effect of SCH39166 on active port responses. However, when SCH39166 was given on FAD40-50, after cue-induced cocaine seeking has incubated, we found a significant suppression of active port responses. We performed a parallel study with L-741,626, a specific D2R antagonist, and similarly found a selective suppression of incubated cue-induced seeking. Our results show for the first time that DA release occurs in the NAcc in conjunction with incubated cue-induced cocaine seeking and is required for its expression.
The magnitude of cue-induced DA release is not altered over incubation although the significance of DA receptor stimulation for cue-induced seeking is changed
When measuring DA release during cue-induced cocaine-seeking tests, and time-locking to the seeking response (active pokes that trigger the cue), we found that the average magnitude of DA release was the same on FAD1-2 and FAD40-50. This suggests that the expression of incubation is not related to an increase in DA release. However, given that DA receptor blockade in the NAcc inhibits incubated seeking (FAD40-50) but not FAD1 seeking, we suggest that postsynaptic adaptations occur during incubation such that the same amount of DA release evokes a greater postsynaptic response. Supporting this possibility, it has long been known that adaptations in DA receptor expression and post-receptor intracellular signaling occur after cocaine exposure [38, 39]. We previously examined surface expression of DA receptors in NAcc after the same cocaine self-administration regimen used here and found no change in D1Rs and small decreases in D2Rs during cocaine incubation [40], so a change in post-receptor signaling seems more likely to account for our results.
We acknowledge that the relationship between the magnitudes of DA release and cue responding may depend on the design of the study. A recent study measured DA release in response to non-contingent presentation of a cue previously paired with cocaine self-administration and found greater DA release after 30 days of forced abstinence [41]. The difference likely reflects the fact that this study measured the DA response to non-contingent cue presentation whereas we measured the DA response to the seeking action paired with the cue. Furthermore, this study did not demonstrate a causal relationship between greater DA release in response to non-contingent cue presentation and the expression of incubated cocaine seeking. Another recent study measured DA release in the lateral NAcs during cocaine seeking in mice and found an increase in the frequency of DA transients measured on FAD24 compared to pre-SA baseline [24]. Finally, in slice voltammetry studies performed in NAcc after 4 weeks of abstinence from cocaine SA regimens leading to incubation of craving, electrically stimulated DA release did not differ significantly from that observed in cocaine-naïve rats, although cocaine was more potent at DA uptake inhibition [42].
Some theories emphasize the significance of DA release not only for learning about cues and rewards but also for encoding motivational vigor and saliency [43,44,45,46]. Our data are generally consistent with these findings although our behavioral task is not designed to isolate these facets of DA-related behavior.
Both D1 and D2 receptors contribute to incubated cue-induced cocaine seeking
Our studies revealed that blocking either the D1R or D2R similarly attenuated incubated cue-induced cocaine seeking. These results are consistent with recent models supporting cooperative interactions between D1R expressing MSN (D1-MSN) and D2R expressing MSN (D2-MSN) in regulating motivated behavior [47,48,49]. It is also important to keep in mind that our pharmacology experiments were focused at the level of D1R and D2R transmission, not D1-MSN and D2-MSN activity. We also acknowledge that DA receptors are present not only on MSN (where they act as neuromodulators to influence excitability, glutamate transmission, and intracellular signaling) but also on other neuronal elements, indicating a multiplicity of potential interactive regulatory mechanisms [50]. Furthermore, these receptors are also present on non-neuronal cells including microglia and astrocytes [51, 52], and there is evidence that these cell types contribute to cocaine incubation [53, 54].
While our study is the first to show that activation of D1R and D2R is required for cocaine incubation, a previous study found that activation of both receptors in NAcc but not shell is required for expression of incubation of methamphetamine craving [55]. Others found that activation of both D1R and D2R in NAcs is necessary and sufficient for drug-primed reinstatement of cocaine seeking [56, 57]. Overall, these results support cooperative actions of DA signaling at D1R and D2R in psychostimulant seeking. Consistent with these findings at the level of the NAc, functional inhibition of VTA DA neurons reduces cocaine reinstatement [58] and cocaine seeking after brief abstinence [59]. Interestingly, intra-NAc injection of a D1R antagonist (SCH 23390) into either core or shell similarly reduced sucrose seeking both before (FAD1) and after (FAD40) sucrose incubation [60]. We suggest that the more pronounced effect after incubation in our cocaine study reflects different NAc adaptations after cocaine versus sucrose incubation [e.g., [61]].
While we focused on D1R and D2R as these are the most widely expressed DA receptors in NAcc, some NAc MSN also express the D3R [62]. Indeed, one study found that a D3R antagonist reduced context-induced cocaine seeking during forced abstinence, although this occurred independent of abstinence duration [63]. Based on this study, it is unlikely that D3R contribute to observed effects of the D2R antagonist L-741,626 on cocaine seeking, as our effects were specific to incubated cue-induced cocaine seeking. However, we acknowledge that there can be differences in mechanisms of cue- and context-induced seeking [64].
Integration with other incubation mechanisms in NAcc
This study demonstrates a role for DA signaling at D1R and D2R in the NAcc in the expression of incubated cocaine seeking, while our previous work has demonstrated that this expression depends on strengthening of glutamate transmission in the NAcc via synaptic insertion of high conductance Ca2+-permeable AMPA receptors (CP-AMPARs) [11, 65,66,67]. CP-AMPAR upregulation in the NAcs is also required for the incubation of cocaine craving [12]. This dual necessity of DA and glutamate suggests these neurotransmitters may be interacting to support incubated cue-induced seeking. There is precedent for such an interaction. For example, the reinforcing properties of the BLA-to-NAc glutamate pathway are gated by D1Rs in the NAc [68]. More generally, DA can alter how MSNs respond to glutamate signaling, although this relationship is complex and not fully understood [16, 50, 69]. One potentially relevant mode of interaction is suggested by the demonstration that D1R activation primes AMPAR for synaptic insertion in cultured NAc neurons [70]. Another possibility is related to the fact that MSNs in vivo have bi-stable resting potentials, existing in a hyperpolarized “down state” and a depolarized “up state” from which they can fire action potentials [71]. DA may be acting through D1R to facilitate transition to the “up state” [72, 73]. Alternatively, DA may indirectly increase MSN activity by reducing inhibitory tone. Activation of D2R on the D2-MSN, which collateralize on D1-MSNs, reduces GABA release from the D2-MSN resulting in a disinhibition of D1-MSN. This mechanism contributes to cocaine-induced locomotor activity [74]. Furthermore, we must consider DA actions on D2R present on cholinergic interneurons, which modulate MSN firing when inhibited via optogenetics [75].
Methodological considerations
There are several methodological issues that should be acknowledged. One potential concern is buffering of DA by the sensor. However, we found no difference in cocaine self-administration and incubation between rats expressing GRAB_DA2m and a mutant sensor that does not bind DA, arguing against substantial buffering. We also acknowledge that we cannot rule out a difference in DA release when comparing FAD1-2 to FAD40-50 that it is too small for our sensor to detect. In regard to pharmacology studies, the major concern is specificity of the chosen drugs for their receptors. SCH39166 was selected based on its high affinity for the D1R relative to other DA and 5-HT receptors [76, 77], while L-741,626 was selected due to its 50-fold higher affinity for the D2R than the D3R [78, 79]. However, we cannot completely rule out the possibility of interactions with other receptors. Another concern with DA receptor antagonism is potential suppression of motor activity, which could reduce responding during seeking tests. To avoid this, we selected a SCH39166 dose that reduced methamphetamine seeking without eliciting motor deficits as measured by operant responding for sucrose/maltodextrin [55]. Consistent with these prior results, we found no significant reduction of locomotion during seeking tests or open field activity. For L-741,626, we likewise found no evidence of non-specific reduction of motor activity, consistent with another study that administered various doses of this drug into NAcc and reported no effects on locomotion [80]. An additional potential concern is a “floor effect” in FAD1 pharmacology studies, although this concern is lessened by our use of a 1-h seeking test during which significant responding occurs even on FAD1. Our lab has successfully conducted such studies in the past [81, 82].
Conclusions
Cue-induced cocaine seeking is accompanied by a similar magnitude of NAcc DA release in early and late abstinence, suggesting that the expression of cocaine incubation does not reflect enhancement of DA release (i.e., a presynaptic effect). Instead, the suppression of incubated seeking (FAD40-50) but not FAD1 seeking by D1R or D2R antagonists suggests that postsynaptic changes occur that enable the same amount of DA release to drive stronger behavioral responding. It will be important for future studies to examine how glutamate and DA interact postsynaptically to set the gain on cue reactivity during cocaine abstinence.
References
Neisewander JL, Baker DA, Fuchs RA, Tran-Nguyen LT, Palmer A, Marshall JF. Fos protein expression and cocaine-seeking behavior in rats after exposure to a cocaine self-administration environment. J Neurosci. 2000;20:798–805.
Grimm JW, Hope BT, Wise RA, Shaham Y. Incubation of cocaine craving after withdrawal. Nature. 2001;412:141–42.
Lu L, Grimm JW, Hope BT, Shaham Y. Incubation of cocaine craving after withdrawal: a review of preclinical data. Neuropharmacology. 2004;47:214–26.
Altshuler RD, Lin H, Li X. Neural mechanisms underlying incubation of methamphetamine craving: a mini-review. Pharm Biochem Behav. 2020;199:173058.
Reiner DJ, Fredriksson I, Lofaro OM, Bossert JM, Shaham Y. Relapse to opioid seeking in rat models: behavior, pharmacology and circuits. Neuropsychopharmacology. 2019;44:465–77.
Pickens CL, Airavaara M, Theberge F, Fanous S, Hope BT, Shaham Y. Neurobiology of the incubation of drug craving. Trends Neurosci. 2011;34:411–20.
Bedi G, Preston KL, Epstein DH, Heishman SJ, Marrone GF, Shaham Y, et al. Incubation of cue-induced cigarette craving during abstinence in human smokers. Biol Psychiatry. 2011;69:708–11.
Wang G, Shi J, Chen N, Xu L, Li J, Li P, et al. Effects of length of abstinence on decision-making and craving in methamphetamine abusers. PLoS ONE. 2013;8:e68791.
Li P, Wu P, Xin X, Fan Y-L, Wang G-B, Wang F, et al. Incubation of alcohol craving during abstinence in patients with alcohol dependence. Addict Biol. 2015;20:513–22.
Parvaz MA, Moeller SJ, Goldstein RZ. Incubation of cue-induced craving in adults addicted to cocaine measured by electroencephalography. JAMA Psychiatry. 2016;73:1127–34.
Wolf ME. Targeting neuroplasticity in substance use disorders: implications for therapeutics. Annu Rev Pharm Toxicol. 2025;65 (In press).
Wright WJ, Dong Y. Psychostimulant-induced adaptations in nucleus accumbens glutamatergic transmission. Cold Spring Harb Perspect Med. 2020;10:a039255.
Keiflin R, Janak PH. Dopamine prediction errors in reward learning and addiction: from theory to neural circuitry. Neuron. 2015;88:247–63.
Berke JD. What does dopamine mean? Nat Neurosci. 2018;21:787–93.
Bamford NS, Wightman RM, Sulzer D. Dopamine’s effects on corticostriatal synapses during reward-based behaviors. Neuron. 2018;97:494–510.
Sippy T, Tritsch NX. Unraveling the dynamics of dopamine release and its actions on target cells. Trends Neurosci. 2023;46:228–39.
Day JJ, Roitman MF, Wightman RM, Carelli RM. Associative learning mediates dynamic shifts in dopamine signaling in the nucleus accumbens. Nat Neurosci. 2007;10:1020–8.
Stuber GD, Klanker M, de Ridder B, Bowers MS, Joosten RN, Feenstra MG, et al. Reward-predictive cues enhance excitatory synaptic strength onto midbrain dopamine neurons. Science. 2008;321:1690–2.
Roitman MF, Wheeler RA, Carelli RM. Nucleus accumbens neurons are innately tuned for rewarding and aversive taste stimuli, encode their predictors, and are linked to motor output. Neuron. 2005;45:587–97.
Ito R, Dalley JW, Howes SR, Robbins TW, Everitt BJ. Dissociation in conditioned dopamine release in the nucleus accumbens core and shell in response to cocaine cues and during cocaine-seeking behavior in rats. J Neurosci. 2000;20:7489–95.
Phillips PEM, Stuber GD, Helen MLAV, Wightman RM, Carelli RM. Subsecond dopamine release promotes cocaine seeking. Nature. 2003;422:614–18.
Aragona BJ, Day JJ, Roitman MF, Cleaveland NA, Wightman RM, Carelli RM. Regional specificity in the real-time development of phasic dopamine transmission patterns during acquisition of a cue-cocaine association in rats. Eur J Neurosci. 2009;30:1889–99.
Luján MÁ, Oliver BL, Young-Morrison R, Engi SA, Zhang L-Y, Wenzel JM, et al. A multivariate regressor of patterned dopamine release predicts relapse to cocaine. Cell Rep. 2023;42:112553.
Pribiag H, Shin S, Wang EH, Sun F, Datta P, Okamoto A, et al. Ventral pallidum DRD3 potentiates a pallido-habenular circuit driving accumbal dopamine release and cocaine seeking. Neuron. 2021;109:2165–82.e10.
Sun F, Zeng J, Jing M, Zhou J, Feng J, Owen SF, et al. A genetically encoded fluorescent sensor enables rapid and specific detection of dopamine in flies, fish, and mice. Cell. 2018;174:481–96.e19.
Sun F, Zhou J, Dai B, Qian T, Zeng J, Li X, et al. Next-generation GRAB sensors for monitoring dopaminergic activity in vivo. Nat Methods. 2020;17:1156–66.
Sherathiya VN, Schaid MD, Seiler JL, Lopez GC, Lerner TN. GuPPy, a Python toolbox for the analysis of fiber photometry data. Sci Rep. 2021;11:24212–12.
Jean-Richard-Dit-Bressel P, Clifford CWG, McNally GP. Analyzing event-related transients: confidence intervals, permutation tests, and consecutive thresholds. Front Mol Neurosci. 2020;13:14.
Liu Y, Jean-Richard-Dit-Bressel P, Yau JO, Willing A, Prasad AA, Power JM, et al. The mesolimbic dopamine activity signatures of relapse to alcohol-seeking. J Neurosci. 2020;40:6409–27.
Yau JO, McNally GP. The activity of ventral tegmental area dopamine neurons during shock omission predicts safety learning. Behav Neurosci. 2022;136:276–84.
Deroche-Gamonet V, Belin D, Piazza PV. Evidence for addiction-like behavior in the rat. Science. 2004;305:1014–17.
Wightman RM, Heien ML, Wassum KM, Sombers LA, Aragona BJ, Khan AS, et al. Dopamine release is heterogeneous within microenvironments of the rat nucleus accumbens. Eur J Neurosci. 2007;26:2046–54.
Zachry JE, Nolan SO, Brady LJ, Kelly SJ, Siciliano CA, Calipari ES. Sex differences in dopamine release regulation in the striatum. Neuropsychopharmacology. 2021;46:491–99.
Yoest KE, Cummings JA, Becker JB. Estradiol, dopamine and motivation. Cent Nerv Syst Agents Med Chem. 2014;14:83–9.
Kerstetter KA, Aguilar VR, Parrish AB, Kippin TE. Protracted time-dependent increases in cocaine-seeking behavior during cocaine withdrawal in female relative to male rats. Psychopharmacol. 2008;198:63–75.
Nicolas C, Russell TI, Pierce AF, Maldera S, Holley A, You ZB, et al. Incubation of cocaine craving after intermittent-access self-administration: sex differences and estrous cycle. Biol Psychiatry. 2019;85:915–24.
Corbett CM, Dunn E, Loweth JA. Effects of sex and estrous cycle on the time course of incubation of cue-induced craving following extended-access cocaine self-administration. eNeuro. 2021;8:ENEURO.0054–21.2021.
White FJ, Wolf ME. Psychomotor stimulants. In: Pratt JA, editor. The biological basis of drug tolerance and dependence. United Kingdom: Academic Press; 1991. p. 153–97.
Anderson SM, Pierce RC. Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement. Pharm Ther. 2005;106:389–403.
Conrad KL, Ford K, Marinelli M, Wolf ME. Dopamine receptor expression and distribution dynamically change in the rat nucleus accumbens after withdrawal from cocaine self-administration. Neuroscience. 2010;169:182–94.
Burgeno LM, Farero RD, Murray NL, Panayi MC, Steger JS, Soden ME, et al. Cocaine seeking and taking are oppositely regulated by dopamine. bioRxiv. 2023:2023.04.09.536189.
Alonso IP, O’Connor BM, Bryant KG, Mandalaywala RK, España RA. Incubation of cocaine craving coincides with changes in dopamine terminal neurotransmission. Addict Neurosci. 2022;3:100029.
Hamid AA, Pettibone JR, Mabrouk OS, Hetrick VL, Schmidt R, Vander Weele CM, et al. Mesolimbic dopamine signals the value of work. Nat Neurosci. 2016;19:117–26.
Mohebi A, Pettibone JR, Hamid AA, Wong J-MT, Vinson LT, Patriarchi T, et al. Dissociable dopamine dynamics for learning and motivation. Nature. 2019;570:65–70.
Kutlu MG, Zachry JE, Melugin PR, Cajigas SA, Chevee MF, Kelley SJ, et al. Dopamine release in the nucleus accumbens core signals perceived saliency. Curr Biol. 2021;31:4748–61.
Jeong H, Taylor A, Floeder JR, Lohmann M, Mihalas S, Wu B, et al. Mesolimbic dopamine release conveys causal associations. Science. 2022;0:eabq6740.
Allichon MC, Ortiz V, Pousinha P, Andrianarivelo A, Petitbon A, Heck N, et al. Cell-type-specific adaptions in striatal medium-sized spiny neurons and their roles in behavioral responses to drugs of abuse. Front Synaptic Neurosci. 2021;13:799274.
Burke DA, Rotstein HG, Alvarez VA. Striatal local circuitry: a new framework for lateral inhibition. Neuron. 2017;96:267–84.
Bariselli S, Fobbs WC, Creed MC, Kravitz AV. A competitive model for striatal action selection. Brain Res. 2019;1713:70–9.
Tritsch NX, Sabatini BL. Dopaminergic modulation of synaptic transmission in cortex and striatum. Neuron. 2012;76:33–50.
Corkrum M, Araque A. Astrocyte-neuron signaling in the mesolimbic dopamine system: the hidden stars of dopamine signaling. Neuropsychopharmacology. 2021;46:1864–72.
Jiménez-González A, Gómez-Acevedo C, Ochoa-Aguilar A, Chavarría A. The role of glia in addiction: dopamine as a modulator of glial responses in addiction. Cell Mol Neurobiol. 2022;42:2109–20.
Kim R, Testen A, Harder EV, Brown NE, Witt EA, Bellinger TJ, et al. Abstinence-dependent effects of long-access cocaine self-administration on nucleus accumbens astrocytes are observed in male, but not female, rats. eNeuro. 2022;9:ENEURO.0310–22.2022.
Reverte I, Marchetti C, Pezza S, Zenoni SF, Scaringi G, Ferrucci L, et al. Microglia-mediated calcium-permeable AMPAR accumulation in the nucleus accumbens drives hyperlocomotion during cocaine withdrawal. Brain Behav Immun. 2024;115:535–42.
Rossi LM, Reverte I, Ragozzino D, Badiani A, Venniro M, Caprioli D. Role of nucleus accumbens core but not shell in incubation of methamphetamine craving after voluntary abstinence. Neuropsychopharmacology. 2020;45:256–65.
Schmidt HD, Pierce RC. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat. Neuroscience. 2006;142:451–61.
Schmidt HD, Anderson SM, Pierce RC. Stimulation of D1-like or D2 dopamine receptors in the shell, but not the core, of the nucleus accumbens reinstates cocaine-seeking behaviour in the rat. Eur J Neurosci. 2006;23:219–28.
Mahler SV, Brodnik ZD, Cox BM, Buchta WC, Bentzley BS, Quintanilla J, et al. Chemogenetic manipulations of ventral tegmental area dopamine neurons reveal multifaceted roles in cocaine abuse. J Neurosci. 2019;39:503.
Solecki W, Wilczkowski M, Pradel K, Karwowska K, Kielbinski M, Drwięga G, et al. Effects of brief inhibition of the ventral tegmental area dopamine neurons on the cocaine seeking during abstinence. Addict Biol. 2020;25:e12826.
Grimm JW, Harkness JH, Ratliff C, Barnes J, North K, Collins S. Effects of systemic or nucleus accumbens-directed dopamine D1 receptor antagonism on sucrose seeking in rats. Psychopharmacology. 2011;216:219–33.
Counotte DS, Schiefer C, Shaham Y, O’Donnell P. Time-dependent decreases in nucleus accumbens AMPA/NMDA ratio and incubation of sucrose craving in adolescent and adult rats. Psychopharmacology. 2014;231:1675–84.
Le Moine C, Bloch B. Expression of the D3 dopamine receptor in peptidergic neurons of the nucleus accumbens: comparison with the D1 and D2 dopamine receptors. Neuroscience. 1996;73:131–43.
Xi ZX, Li X, Li J, Peng XQ, Song R, Gaál J, et al. Blockade of dopamine D3 receptors in the nucleus accumbens and central amygdala inhibits incubation of cocaine craving in rats. Addict Biol. 2013;18:665–77.
Fuchs RA, Lasseter HC, Ramirez DR, Xie X. Relapse to drug seeking following prolonged abstinence: the role of environmental stimuli. Drug Discov Today Dis Models. 2008;5:251–58.
Conrad KL, Tseng KY, Uejima JL, Reimers JM, Heng LJ, Shaham Y, et al. Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving. Nature. 2008;454:118–21.
Loweth JA, Scheyer AF, Milovanovic M, LaCrosse AL, Flores-Barrera E, Werner CT, et al. Synaptic depression via mGluR1 positive allosteric modulation suppresses cue-induced cocaine craving. Nat Neurosci. 2014;17:73–80.
Kawa AB, Hwang EK, Funke JR, Zhou H, Costa-Mattioli M, Wolf ME. Positive allosteric modulation of mGlu1 reverses cocaine-induced behavioral and synaptic plasticity through the integrated stress response and oligophrenin-1. Biol Psychiatry. 2022;92:871–79.
Stuber GD, Sparta DR, Stamatakis AM, van Leeuwen WA, Hardjoprajitno JE, Cho S, et al. Excitatory transmission from the amygdala to nucleus accumbens facilitates reward seeking. Nature. 2011;475:377–80.
Nicola SM, Surmeier J, Malenka RC. Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu Rev Neurosci. 2000;23:185–215.
Sun X, Milovanovic M, Zhao Y, Wolf ME. Acute and chronic dopamine receptor stimulation modulates AMPA receptor trafficking in nucleus accumbens neurons cocultured with prefrontal cortex neurons. J Neurosci. 2008;28:4216–30.
O’Donnell P. Dopamine gating of forebrain neural ensembles. Eur J Neurosci. 2003;17:429–35.
Tseng KY, Snyder-Keller A, O’Donnell P. Dopaminergic modulation of striatal plateau depolarizations in corticostriatal organotypic cocultures. Psychopharmacology. 2007;191:627–40.
Flores-Barrera E, Vizcarra-Chacón BJ, Bargas J, Tapia D, Galarraga E. Dopaminergic modulation of corticostriatal responses in medium spiny projection neurons from direct and indirect pathways. Front Syst Neurosci. 2011;5:15.
Dobbs LK, Kaplan AR, Lemos JC, Matsui A, Rubinstein M, Alvarez VA. Dopamine regulation of lateral inhibition between striatal neurons gates the stimulant actions of cocaine. Neuron. 2016;90:1100–13.
Witten IB, Lin SC, Brodsky M, Prakash R, Diester I, Anikeeva P, et al. Cholinergic interneurons control local circuit activity and cocaine conditioning. Science. 2010;330:1677–81.
Alburges ME, Hunt ME, McQuade RD, Wamsley JK. D1-receptor antagonists: comparison of [3H]SCH39166 to [3H]SCH23390. J Chem Neuroanat. 1992;5:357–66.
McQuade RD, Duffy RA, Coffin VL, Chipkin RE, Barnett A. In vivo binding of SCH 39166: a D-1 selective antagonist. J Pharm Exp Ther. 1991;257:42–9.
Grundt P, Husband SLJ, Luedtke RR, Taylor M, Newman AH. Analogues of the dopamine D2 receptor antagonist L741,626: binding, function, and SAR. Bioorg Med Chem Lett. 2007;17:745–49.
Kulagowski JJ, Broughton HB, Curtis NR, Mawer IM, Ridgill MP, Baker R, et al. 3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor. J Med Chem. 1996;39:1941–2.
Papp M, Gruca P, Lason-Tyburkiewicz M, Litwa E, Niemczyk M, Tota-Glowczyk K, et al. Dopaminergic mechanisms in memory consolidation and antidepressant reversal of a chronic mild stress-induced cognitive impairment‘. Psychopharmacology. 2017;234:2571–85.
Werner CT, Stefanik MT, Milovanovic M, Caccamise A, Wolf ME. Protein translation in the nucleus accumbens is dysregulated during cocaine withdrawal and required for expression of incubation of cocaine craving. J Neurosci. 2018;38:2683–97.
Christian DT, Stefanik MT, Bean LA, Loweth JA, Wunsch AM, Funke JR, et al. GluN3-containing NMDA receptors in the rat nucleus accumbens core contribute to incubation of cocaine craving. J Neurosci. 2021;41:8262–77.
Acknowledgements
We thank Dr. John Williams for providing the GRAB_DA2m virus, Dr. Rajtarun Madangopal for assistance with MedPC code and python code, Dr. Venus Sherathiya for assistance with GuPPy, and Randall Olson for assistance with MATLAB code.
Funding
F31 DA057063 to SJW (as well as support from T32 DA007262); K99-R00 DA057360 to ABK; DA049930 and OHSU startup funds to MEW.
Author information
Authors and Affiliations
Contributions
SJW and MEW developed the experiments and wrote the manuscript. SJW, ABK, MMB, HMK, ALM, JGW, LMK, and CDM conducted the experiments. AMW provided input on fiber photometry.
Corresponding author
Ethics declarations
Competing interests
MEW and OHSU have a financial interest in Eleutheria Pharmaceuticals LLC, a company that may have a commercial interest in results related to the research described herein. This potential conflict of interest has been reviewed and managed by OHSU. Wolf also serves as a Consultant for the University of Texas-Austin and has received compensation. The other authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Weber, S.J., Kawa, A.B., Beutler, M.M. et al. Dopamine transmission at D1 and D2 receptors in the nucleus accumbens contributes to the expression of incubation of cocaine craving. Neuropsychopharmacol. (2024). https://doi.org/10.1038/s41386-024-01992-2
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41386-024-01992-2
- Springer Nature Switzerland AG